Defense prepares Unternehmensupdate and arranges Finanzierung, IR-WORLD.com Finanzkommunikation GmbH, Story

Defense Therapeutics Inc. (“Defence” oder das “Unternehmen”), (CSE: DTC, OTCQB: DTCFF, FWB: DTC), a Canadian Biopharmaceuticals Unternehmen, the Radiopharmaceutika and new Immunonkologie-Impfstoffe and Technologies zur Arzneimittelverabreichung entwickelt, freut sich ein An internal update and a financing round can take place.

It may be that Sebastien Plouffe, Gründer and Director of Defense, with such a strong Wirkung, will start working as Chief Executive Officer. Mr. Plouffe has ended this phase for the current phase of the program, one of the efficient results of the program, the commercialization of the company and the financing of financial resources for the subdivisions. Mr. Kwin Grauer, the lord of the Abwesenheit of Herrn Plouffe as interim CEO, has relieved the role of the Board of Directors. The Unternehmen thanks Herrn Grauer for his Commitment and his Bemühungen um das Wachstum von Defense.

The Unternehmen can get a new appointment for its Board of Directors: Dr. Philippe Lefrançois and Mr. Arnab De as Ersatz for Dr. Moutih Rafei, from the Board of Directors zurücktritt, with more CSO bleibt, bzw. Herrn Joseph Meagher, member of the Board of Directors, has started the new phase of the new CFO. Herrn Arnab The new CFO is acting. Our colleagues thanked Dr. Rafei and Herrn Meagher for their work on the Board of Directors.

Dr. Philippe Lefrançois is directorector of research at the Abteilung für Dermatologie at McGill University. There is an assistant professor for Medizin, Pharmacology, Therapeutik and for Surgery. There is a full-time dermatologist at the Jewish General Hospital, who is active in the multidisciplinary operation of Hautkrebskliniken and Tumorboards. There is a Prüfer at the Lady Davis Institute, where a umfassende Hautkrebs-Biobank und a Labor für vertalerische Genomik für Hautkrebs gründete. The Terry Fox Research Institute – Marathon of Hope Cancer Center Network initiative has begun for BCC and SCC. There is Mitglied des Réseau Recherche Cancer – Québec and the Québec Cancer Consortium. If you translate into a collaboration with biotech companies, there is a new Krebs therapeutic and diagnostic diagnosis in practice and phase I study that you can bring. Dr. Lefrançois has a Ph.D. von der Yale University and an MD from the Université de Montréal. There is absolutely no dermatology facharztausbildung at McGill. Seine Arbeit im Bereich Hautkrebs could benefit from the CDA and the AAD.

Herr Arnab De, CPA, CGMA, CMA, MBA, has done long-term research into the financial sector with more than 20 years of experience in financial management, financial planning, optimization and strategy. There is Leiter from Resurgent Montreal Inc., a financial management assessment firm. This job is 19 years ago in the Tata Group and has a CFO position at JCAPCPL (a 50:50 JV von Tata Steel with Nippon Steel), the Automobilstähle restores, and Tata Steel Minerals Canada Ltd., where the DSO project The Gründung is a beautiful one and an investment of more than 1.5 billion. $ in Own Capital and Debts. Mr. De ist derzeit auch CFO for the business company.

“Dr. Philippe Lefrançois guards against the accum^®-Platform technology of defense equipment, which is one of the practical studies of ARM-X^T.M going to war, there is a potential excess. Because the melanoma was specialized, Vorteil’s defense was clinically conducting a Phase I trial of AccuTOX^® as an anti-krebs drug in patients with melanoma of the council and the research can (on July 8, 2024, in the defense, this is the ‘letter of no objection’ from Health Canada for the phase I study). Herr Arnab is responsible for a comprehensive financial planning, strategy and regulatory framework for a major future development,” said Sebastien Plouffe, Chief Executive Officer of Defense Therapeutics.

If you want to take more than 200,000 Defense Incentive Action Options and the next step, 200,000 Incentive Action Options are available and both new directors will be expanded: 100,000 Incentive Action Options and Dr. Lefrançois and 100,000 Incentive-Aktienoptionen and Herrn De . This promotion option is as easy as possible and can last once a year before the purchase date will get a price of 0.60$ for the promotion that is running.

If you get a private company, there is a broker involvement from $3 million to $0.50 for an amount that is worth $6 million. Jede is the best of a pedigree in the Kapital des Unternehmens and has received an Aktienkaufwarrant. Your entire Warrant is entitled to receive the Inhaber zum Erwerb a sister action for a price of $ 1.00 per action for a period of 24 months after the withdrawal date.

If you are looking for an alternative, the net worth of the weiterentwicklung is used for clinical and clinical programs that use all types of working capital. It is worth making a commitment to the direction of the CSE in the future. The imprint of the Angebots is removed by writing the forms of the CSE, one of the four Monats and a Tag on the Abschlussdatum.

Uber Defense:

Defense Therapeutics is a clinical-stage research company in the biotech industry that offers a proprietary platform for companies developing the next generation of impfants and ADC products. The core Defense Therapeutics platform is the best in the ACCUM^®-Technology, which allows excellent transport of impfantigens or ADCs in the import form to the Zielzellen. If you take the next step, you can experience improved functioning and functioning that will improve the functioning of credits and infectious diseases.

Vorsorglicher Hinweis bezüglich „zukunftsgerichteter“ Informationen

This press conference has produced the best results, which have been built in as “zukunftsoriented expressions”. If you have become a parent, all events during that period, if you make a beginning or a division, are a fact that someone else fails to pay attention to a focused Aussagen. Zukunftsgerichtte Aussagen, if it is a historical event, it is all – jedoch nicht immer – durch Begriffe with “erwartet”, “plant”, “antizipiert”, “glaubt”, “beabsichtigt”, “schätzt”, “prognostiziert “, “ möglich” und vergleichbare Ausdrücke or Aussagen, wonach bestimmte Ereignisse or Bedingungen eintreten “werden”, “würden”, “könnten” or “solllten”, gekennzeichnet. Once the research has started, it is true that you get the right guarantee for the positive targeting and that the tatsächlichen can be answered very well in those specific Zukunft-oriented measures and Angaben abweichen. If the factory tower leaves the company, then the most important issues in the emerging economies of the market will be viewed, the market price and the continued capital and financing activities wie allgemeine Wirtschafts-, Markt-oder Geschäftsbedingungen. Although there are more and more hinges, the only guarantee for the proper care of the body and the tactile health or care that can be taken into account can be the result of these health-related problems. The expenditure related to expenditure falls under the umbrella of the assessments and reports of the management of external human resources and the results of the assessment. If you do not go through the paperwork, it will not be possible to increase the independence of the business activities, if you take over the debts or management of other companies or other factories.

The CSE and the market regulatory body (which is the definition of the CSE definition) do not have any responsibility for the Angemessenheit or Richtigkeit dies Mitteilung.

The Ausgangssprache (in the Rule English), in the original text which is light, is the official, authorizing and legally binding version. These instructions can be carried out with confidence. The German language can be kürzt or jijammengefasst. There is no Verantwortung or Haftung für de Inhalt, de Direction, de Angemessenheit or de Genauigkeit dieser Übersetzung übernommen. Aus Sicht des Übersetzers stelltt die Notification keine Kauf- oder Verkaufsempfehlung dar! Bitte beachten See the English original report on www.sedarplus.ca, www.sec.gov, www.asx.com.au/ or on the Firmen website!

About us at the IRW-Press News-Service der IR-WORLD.com Finanzkommunikation GmbH

For the Inhalt der Mitteilung bzw. The research is the sole responsibility of the author of the Nachricht. This notification is not a single notification or notification of the best coupon.